Sachin N Desai

Summary

Affiliation: International Vaccine Institute

Publications

  1. doi A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia
    Sachin N Desai
    International Vaccine Institute, Seoul, Korea Armauer Hansen Research Institute, Addis Ababa, Ethiopia
    Am J Trop Med Hyg 93:527-33. 2015
  2. doi An overview of cholera vaccines and their public health implications
    Sachin N Desai
    International Vaccine Institute, Seoul, South Korea
    Curr Opin Pediatr 24:85-91. 2012
  3. doi Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings
    Sachin N Desai
    International Vaccine Institute, Seoul, Korea
    Trop Med Int Health 21:194-201. 2016
  4. doi Oral vaccines against cholera
    Sunheang Shin
    International Vaccine Institute, Seoul, South Korea
    Clin Infect Dis 52:1343-9. 2011
  5. doi A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines
    Yeong Ok Baik
    EuBiologics Co, Ltd, Seoul, Republic of Korea Department of Biotechnology, Korea University, Seoul, Republic of Korea
    Vaccine 33:6360-5. 2015

Collaborators

  • John D Clemens
  • Yeong Ok Baik
  • Sunheang Shin
  • May B Montellano
  • Chan Wha Kim
  • Jae Seung Yang
  • Ajit Pal Singh
  • Seuk Keun Choi
  • Roberto A Espos
  • Antonio D Ligsay
  • Jong Sun Yeam
  • Remigio M Olveda
  • Deok Ryun Kim
  • Sue Nie Park
  • Ick Young Kim
  • Ju Yeon Park
  • Binod K Sah

Detail Information

Publications5

  1. doi A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia
    Sachin N Desai
    International Vaccine Institute, Seoul, Korea Armauer Hansen Research Institute, Addis Ababa, Ethiopia
    Am J Trop Med Hyg 93:527-33. 2015
    ..This is the first study to evaluate safety and immunogenicity of the vaccine in a population outside Asia using a placebo-controlled, double-blind, randomized study design. ..
  2. doi An overview of cholera vaccines and their public health implications
    Sachin N Desai
    International Vaccine Institute, Seoul, South Korea
    Curr Opin Pediatr 24:85-91. 2012
    ....
  3. doi Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings
    Sachin N Desai
    International Vaccine Institute, Seoul, Korea
    Trop Med Int Health 21:194-201. 2016
    ....
  4. doi Oral vaccines against cholera
    Sunheang Shin
    International Vaccine Institute, Seoul, South Korea
    Clin Infect Dis 52:1343-9. 2011
    ..The advent of safe and effective, new-generation oral vaccines against cholera has created renewed interest in the use of vaccines as a tool to control cholera...
  5. doi A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines
    Yeong Ok Baik
    EuBiologics Co, Ltd, Seoul, Republic of Korea Department of Biotechnology, Korea University, Seoul, Republic of Korea
    Vaccine 33:6360-5. 2015
    ..As the global supply of OCV remains limited, we assessed the safety and immunogenicity of a new low cost, killed, bivalent OCV (Euvichol) in the Philippines...